Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

March 30, 2022

Primary Completion Date

February 17, 2026

Study Completion Date

July 31, 2026

Conditions
Acne
Interventions
DRUG

Spironolactone

Dispensation of spironolactone according to the arm description.

DRUG

Doxycycline Hyclate

Dispensation of doxycycline hyclate according to the arm description.

Trial Locations (18)

10016

New York University, New York

11042

Northwell Health, North New Hyde Park

19104

Children's Hospital of Philadelphia, Philadelphia

33136

University of Miami, Miami

33165

New Horizon Research Center, Miami

43215

Ohio State University Medical Center, Columbus

45209

University of Pennsylvania, Philadelphia

45242

Dermatologists of Central States, Cincinnati

46250

Dawes Fretzin Clinical Research Group, Indianapolis

72916

Johnson Dermatology, Fort Smith

75034

North Texas Center for Clinical Research, Frisco

76011

Arlington Research Center, Arlington

77004

CCS Texas, Houston

92866

Cura Clinical Research, Sherman Oaks

94115

University of California San Francisco, San Francisco

97030

Cyn3rgy Research, Gresham

97239

Oregon Health and Science University, Portland

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT04582383 - Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne | Biotech Hunter | Biotech Hunter